Haley Geertsma completed her PhD in 2024 under the supervision of Dr. Maxime Rousseaux from the University of Ottawa. Her thesis aimed to investigate the consequences of the chronic nuclear accumulation of alpha-synuclein in a mouse model of Parkinson’s disease. Her research involved mapping the cell-specific topography of alpha-synuclein, characterizing a novel mouse model, and using TurboID to identify the nuclear alpha-synuclein-specific interactome.
Haley’s research interests are centered around understanding the molecular mechanism of disease. Haley has joined the Lochmüller lab as a postdoctoral fellow to use patient-derived stem cells to discover new drug therapies for myotonic dystrophy.
